| Dr William D Weidner, MD | |
|
717 N 190th Plz, Suite #1100, Elkhorn, NE 68022-3917 | |
| (402) 815-1700 | |
| (402) 815-1959 |
| Full Name | Dr William D Weidner |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 40 Years |
| Location | 717 N 190th Plz, Elkhorn, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881705234 | NPI | - | NPPES |
| 1881705234 | Medicaid | NE | |
| 10026301600 | Medicaid | NE | |
| 47068731799 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 17012 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Methodist Hospital | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians Clinic Inc | 4880506062 | 497 |
News Archive
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2010 ended July 31, 2009. Total revenues for the first quarter of FY 2010 increased 345% to $6,750,000, compared to $1,517,000 for the comparable prior year quarter. This increase was primarily generated from increased government contract revenue and from increased sales by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary.
Researchers suspect that a protein superstructure called amyloid beta is responsible for much of the neural damage of Alzheimer's disease. A new study at the University of California, San Diego, shows that amyloid beta disrupts one of the brain's anti-oxidant proteins and demonstrates a way to protect that protein, and perhaps others, from amyloid's harmful effects.
The Diabetes Resource Center at Sinai Hospital of Baltimore has been awarded recertification by the American Diabetes Association Education Recognition program.
Two key focus areas of Biocell Center, the nation's first amniotic fluid stem cell bank, have been recently mentioned among the most important medical discoveries of the last century. Amniocentesis and non-embryonic stem cells were among the list of "Huge Medical Breakthroughs" presented in an article by Althea Chang on Mainstreet.com, produced by TheStreet.com on June 29, 2010.
A new analysis of 585 large, randomized clinical trials registered with ClinicalTrials.gov finds that 29 percent have not been published in scientific journals. In addition, nearly 78 percent of the unpublished trials had no results available on the website, either.
› Verified 8 days ago
| Entity Name | Physicians Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821049156 PECOS PAC ID: 4880506062 Enrollment ID: O20031105000345 |
News Archive
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2010 ended July 31, 2009. Total revenues for the first quarter of FY 2010 increased 345% to $6,750,000, compared to $1,517,000 for the comparable prior year quarter. This increase was primarily generated from increased government contract revenue and from increased sales by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary.
Researchers suspect that a protein superstructure called amyloid beta is responsible for much of the neural damage of Alzheimer's disease. A new study at the University of California, San Diego, shows that amyloid beta disrupts one of the brain's anti-oxidant proteins and demonstrates a way to protect that protein, and perhaps others, from amyloid's harmful effects.
The Diabetes Resource Center at Sinai Hospital of Baltimore has been awarded recertification by the American Diabetes Association Education Recognition program.
Two key focus areas of Biocell Center, the nation's first amniotic fluid stem cell bank, have been recently mentioned among the most important medical discoveries of the last century. Amniocentesis and non-embryonic stem cells were among the list of "Huge Medical Breakthroughs" presented in an article by Althea Chang on Mainstreet.com, produced by TheStreet.com on June 29, 2010.
A new analysis of 585 large, randomized clinical trials registered with ClinicalTrials.gov finds that 29 percent have not been published in scientific journals. In addition, nearly 78 percent of the unpublished trials had no results available on the website, either.
› Verified 8 days ago
| Entity Name | Nebraska Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689628372 PECOS PAC ID: 6901707447 Enrollment ID: O20040116000781 |
News Archive
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2010 ended July 31, 2009. Total revenues for the first quarter of FY 2010 increased 345% to $6,750,000, compared to $1,517,000 for the comparable prior year quarter. This increase was primarily generated from increased government contract revenue and from increased sales by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary.
Researchers suspect that a protein superstructure called amyloid beta is responsible for much of the neural damage of Alzheimer's disease. A new study at the University of California, San Diego, shows that amyloid beta disrupts one of the brain's anti-oxidant proteins and demonstrates a way to protect that protein, and perhaps others, from amyloid's harmful effects.
The Diabetes Resource Center at Sinai Hospital of Baltimore has been awarded recertification by the American Diabetes Association Education Recognition program.
Two key focus areas of Biocell Center, the nation's first amniotic fluid stem cell bank, have been recently mentioned among the most important medical discoveries of the last century. Amniocentesis and non-embryonic stem cells were among the list of "Huge Medical Breakthroughs" presented in an article by Althea Chang on Mainstreet.com, produced by TheStreet.com on June 29, 2010.
A new analysis of 585 large, randomized clinical trials registered with ClinicalTrials.gov finds that 29 percent have not been published in scientific journals. In addition, nearly 78 percent of the unpublished trials had no results available on the website, either.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William D Weidner, MD Po Box 3755, Omaha, NE 68103-0755 Ph: (402) 354-2100 | Dr William D Weidner, MD 717 N 190th Plz, Suite #1100, Elkhorn, NE 68022-3917 Ph: (402) 815-1700 |
News Archive
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2010 ended July 31, 2009. Total revenues for the first quarter of FY 2010 increased 345% to $6,750,000, compared to $1,517,000 for the comparable prior year quarter. This increase was primarily generated from increased government contract revenue and from increased sales by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary.
Researchers suspect that a protein superstructure called amyloid beta is responsible for much of the neural damage of Alzheimer's disease. A new study at the University of California, San Diego, shows that amyloid beta disrupts one of the brain's anti-oxidant proteins and demonstrates a way to protect that protein, and perhaps others, from amyloid's harmful effects.
The Diabetes Resource Center at Sinai Hospital of Baltimore has been awarded recertification by the American Diabetes Association Education Recognition program.
Two key focus areas of Biocell Center, the nation's first amniotic fluid stem cell bank, have been recently mentioned among the most important medical discoveries of the last century. Amniocentesis and non-embryonic stem cells were among the list of "Huge Medical Breakthroughs" presented in an article by Althea Chang on Mainstreet.com, produced by TheStreet.com on June 29, 2010.
A new analysis of 585 large, randomized clinical trials registered with ClinicalTrials.gov finds that 29 percent have not been published in scientific journals. In addition, nearly 78 percent of the unpublished trials had no results available on the website, either.
› Verified 8 days ago
Judith Ann Scott, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz, Ste. #1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Annamaria Nagy, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz, Ste 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Dr. Kristen L Hoffman, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 717 N 190th Plz, Ste. 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Neil A Hamill, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 No. 190th Plaza, Suite 2400, Elkhorn, NE 68022 Phone: 402-815-1970 Fax: 402-815-1595 | |
Mark D. Carlson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz, Ste. # 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Dr. Julia K Bishop, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz, Ste. 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Allison H. Phillips, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz, Ste. 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 |